Venkatesan Jayaprakash

2.8k total citations
122 papers, 2.3k citations indexed

About

Venkatesan Jayaprakash is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Venkatesan Jayaprakash has authored 122 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 47 papers in Organic Chemistry and 22 papers in Pharmacology. Recurrent topics in Venkatesan Jayaprakash's work include Synthesis and biological activity (32 papers), Computational Drug Discovery Methods (15 papers) and Cholinesterase and Neurodegenerative Diseases (13 papers). Venkatesan Jayaprakash is often cited by papers focused on Synthesis and biological activity (32 papers), Computational Drug Discovery Methods (15 papers) and Cholinesterase and Neurodegenerative Diseases (13 papers). Venkatesan Jayaprakash collaborates with scholars based in India, Türkiye and United States. Venkatesan Jayaprakash's co-authors include Barij Nayan Sinha, Gülberk Uçar, Surender Singh Jadav, Vishnu Nayak Badavath, Arijit Basu, Sabina Yasmin, İpek Baysal, Mohd Usman Mohd Siddique, Bijo Mathew and Githa Elizabeth Mathew and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Venkatesan Jayaprakash

116 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Venkatesan Jayaprakash India 30 1.1k 748 456 310 240 122 2.3k
Tanos C. C. França Brazil 27 574 0.5× 706 0.9× 672 1.5× 603 1.9× 153 0.6× 162 2.6k
Barij Nayan Sinha India 25 637 0.6× 550 0.7× 278 0.6× 220 0.7× 175 0.7× 108 1.6k
Dharmendra Kumar Yadav India 33 760 0.7× 1.5k 2.0× 421 0.9× 574 1.9× 220 0.9× 196 3.7k
Vinod Kumar India 30 1.1k 1.0× 933 1.2× 479 1.1× 307 1.0× 61 0.3× 121 2.7k
Ashfaq Ur Rehman Pakistan 31 1.1k 1.0× 1.3k 1.7× 239 0.5× 528 1.7× 161 0.7× 122 2.9k
Iqrar Ahmad India 33 1.6k 1.5× 1.1k 1.5× 378 0.8× 726 2.3× 159 0.7× 165 3.1k
Sankaranarayanan Murugesan India 32 1.7k 1.5× 1.1k 1.5× 332 0.7× 449 1.4× 307 1.3× 204 3.4k
Maria do Carmo Alves de Lima Brazil 30 1.3k 1.2× 922 1.2× 250 0.5× 143 0.5× 84 0.3× 178 2.7k
Michel Baltas France 31 1.9k 1.8× 1.2k 1.6× 271 0.6× 178 0.6× 276 1.1× 143 3.1k
Rossella Fioravanti Italy 27 1.1k 1.0× 839 1.1× 432 0.9× 157 0.5× 184 0.8× 75 2.3k

Countries citing papers authored by Venkatesan Jayaprakash

Since Specialization
Citations

This map shows the geographic impact of Venkatesan Jayaprakash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Venkatesan Jayaprakash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Venkatesan Jayaprakash more than expected).

Fields of papers citing papers by Venkatesan Jayaprakash

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Venkatesan Jayaprakash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Venkatesan Jayaprakash. The network helps show where Venkatesan Jayaprakash may publish in the future.

Co-authorship network of co-authors of Venkatesan Jayaprakash

This figure shows the co-authorship network connecting the top 25 collaborators of Venkatesan Jayaprakash. A scholar is included among the top collaborators of Venkatesan Jayaprakash based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Venkatesan Jayaprakash. Venkatesan Jayaprakash is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rakshit, Gourav, Biswatrish Sarkar, Barij Nayan Sinha, et al.. (2025). Identification of novel thiazole derivatives as flaviviral protease inhibitors effective against Dengue (DENV2) and Japanese encephalitis viruses. Antimicrobial Agents and Chemotherapy. 69(4). e0165124–e0165124. 2 indexed citations
2.
Laghezza, Antonio, Federica Gilardi, Aurélien Thomas, et al.. (2025). A new potent and selective peroxisome proliferator-activated receptor alpha partial agonist displays anti-steatotic effects In vitro and behaves as a safe hypolipidemic and hypoglycemic agent in a diabetic mouse model. European Journal of Medicinal Chemistry. 289. 117494–117494. 1 indexed citations
3.
Jannuzzi, Ayşe Tarbın, Ayşe Mine Yılmaz, Hatice Yıldırım, et al.. (2024). Prospects for Prostate Cancer Chemotherapy: Cytotoxic Evaluation and Mechanistic Insights of Quinolinequinones with ADME/PK Profile. Biomedicines. 12(6). 1241–1241.
4.
Jayaprakash, Venkatesan, et al.. (2024). Building a ML-based QSAR model for predicting the bioactivity of therapeutically active drug class with imidazole scaffold. SHILAP Revista de lepidopterología. 11. 100148–100148. 5 indexed citations
5.
Thakur, Abhishek, et al.. (2024). Mycobactin analogue interacting with siderophore efflux-pump protein: insights from molecular dynamics simulations and whole-cell assays. SHILAP Revista de lepidopterología. 3. 1362516–1362516. 1 indexed citations
6.
Laghezza, Antonio, Carmen Cerchia, Erica Pranzini, et al.. (2023). A New Antidiabetic Agent Showing Short- and Long-Term Effects Due to Peroxisome Proliferator-Activated Receptor Alpha/Gamma Dual Agonism and Mitochondrial Pyruvate Carrier Inhibition. Journal of Medicinal Chemistry. 66(5). 3566–3587. 5 indexed citations
7.
Yadav, Pragya D., P. Mukherjee, Samsher Singh, et al.. (2023). Rationally Designed Novel Phenyloxazoline Synthase Inhibitors: Chemical Synthesis and Biological Evaluation to Accelerate the Discovery of New Antimycobacterial Antibiotics. Molecules. 28(24). 8115–8115. 2 indexed citations
8.
Yılmaz, Ayşe Mine, Ayşe Tarbın Jannuzzi, Hatice Yıldırım, et al.. (2023). Analysis of Quinolinequinone Analogs with Promising Cytotoxic Activity against Breast Cancer. Chemistry & Biodiversity. 20(9). e202300848–e202300848. 3 indexed citations
9.
Jannuzzi, Ayşe Tarbın, Ayşe Mine Yılmaz, Nilüfer Bayrak, et al.. (2022). Exploring the Anticancer Effects of Brominated Plastoquinone Analogs with Promising Cytotoxic Activity in MCF-7 Breast Cancer Cells via Cell Cycle Arrest and Oxidative Stress Induction. Pharmaceuticals. 15(7). 777–777. 4 indexed citations
10.
Chatterjee, Amrita, et al.. (2022). Molecular Determinants, Clinical Manifestations and Effects of Immunization on Cardiovascular Health During COVID-19 Pandemic Era - A Review. Current Problems in Cardiology. 48(8). 101250–101250. 2 indexed citations
11.
Sarkar, Biswatrish, et al.. (2021). A Critical Observation on the Design and Development of ReportedPeptide Inhibitors of DENV NS2B-NS3 Protease in the Last Two Decades. Mini-Reviews in Medicinal Chemistry. 22(8). 1108–1130. 1 indexed citations
13.
Abdelnabi, Rana, Carmen Mirabelli, Justin W. Flatt, et al.. (2019). A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses. PLoS Biology. 17(6). e3000281–e3000281. 36 indexed citations
14.
Sonawane, Vinay R., Mohd Usman Mohd Siddique, Surender Singh Jadav, et al.. (2019). Cink4T, a quinazolinone-based dual inhibitor of Cdk4 and tubulin polymerization, identified via ligand-based virtual screening, for efficient anticancer therapy. European Journal of Medicinal Chemistry. 165. 115–132. 35 indexed citations
15.
Basha, Syed Hussain, Rana Abdelnabi, Johan Neyts, et al.. (2017). In silico development of a novel putative inhibitor of the 3C protease of Coxsackievirus B3 with a benzene sulfonamide skeleton. 4(3). 25–34. 1 indexed citations
16.
Yasmin, Sabina & Venkatesan Jayaprakash. (2016). DESIGN, IN-SILICO DOCKING AND PREDICTIVE ADME PROPERTIES OF SOME THIAZOLIDINE-2, 4-DIONES DERIVATIVES AS PPARγ MODULATORS. International Journal of Pharmacy and Pharmaceutical Sciences. 8(5). 143–150. 1 indexed citations
17.
Badavath, Vishnu Nayak, Barij Nayan Sinha, & Venkatesan Jayaprakash. (2015). DESIGN, IN-SILICO DOCKING AND PREDICTIVE ADME PROPERTIES OF NOVEL PYRAZOLINE DERIVATIVES WITH SELECTIVE HUMAN MAO INHIBITORY ACTIVITY. International Journal of Pharmacy and Pharmaceutical Sciences. 7(12). 277–282. 9 indexed citations
18.
Badavath, Vishnu Nayak, İpek Baysal, Gülberk Uçar, et al.. (2015). MAO inhibitory activity of Ferulic Acid Amides: Curcumin based design and synthesis. 1 indexed citations
19.
Jadav, Surender Singh, Barij Nayan Sinha, Rolf Hilgenfeld, et al.. (2014). Thiazolidone derivatives as inhibitors of chikungunya virus. European Journal of Medicinal Chemistry. 89. 172–178. 52 indexed citations
20.
Jadav, Surender Singh, et al.. (2014). Chikungunya epidemiological survey and Current available inhibitors. 1(3). 59–67. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026